Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-25-003590·Aligos Therapeutics, Inc.
Schedule 13G ownership disclosure
Aligos Therapeutics Inc
Voting Common Stock, par value $0.0001 per share · CUSIP: 01626L204
Event date: 2025-06-30
- Filing-level shares
- 518,300.00
- Percent of class
- 9.8%
- Woodline Partners LP
Shares: 518,300.00 · Class: 9.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-003590
- Form type
- SCHEDULE 13G/A
- Filer
- Aligos Therapeutics, Inc.
- CIK
- CIK 1799448
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership